Hossein Salehi

Dr. Hossein Salehi


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2016 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
HMHamed Mirzaei
Hamed Mirzaei
GNGholamreza Naseri
Gholamreza Naseri
RRRamin Rezaee
Ramin Rezaee
MMMohsen Mohammadi
Mohsen Mohammadi
ZBZarrin Banikazemi
Zarrin Banikazemi
Amirhossein SahebkarAmirhossein Sahebkar
Amirhossein Sahebkar

1 August 2015 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
MMMohammad Mehrasa
Mohammad Mehrasa
MAMohammad Ali Asadollahi
Mohammad Ali Asadollahi
KGKamran Ghaedi
Kamran Ghaedi
HSHossein Salehi
Hossein Salehi
AAAyyoob Arpanaei
Ayyoob Arpanaei

22 June 2017 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
HMHamed Mirzaei
Hamed Mirzaei
FMFatemeh Momeni
Fatemeh Momeni
LSLeila Saadatpour
Leila Saadatpour
ASAmirhossein Sahebkar
Amirhossein Sahebkar
MGMohammad Goodarzi
Mohammad Goodarzi
MJMahmoud Reza Jaafari
Mahmoud Reza Jaafari

1 April 2020 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
AEAsghar Eskandarinia
Asghar Eskandarinia
AKAmirhosein Kefayat
Amirhosein Kefayat
MGMosayeb Gharakhloo
Mosayeb Gharakhloo
MAMaria Agheb
Maria Agheb
DKDarioush Khodabakhshi
Darioush Khodabakhshi
HSHossein Salehi
Hossein Salehi

10 November 2016 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
ASAmirhossein Sahebkar
Amirhossein Sahebkar
MMMohsen Mohammadi
Mohsen Mohammadi
RYReza Yari
Reza Yari
HSHossein Salehi
Hossein Salehi
MJMohammad Jafari
Mohammad Jafari
HMHamed Mirzaei
Hamed Mirzaei
Hepatocellular carcinoma (HCC) is one of the most common types of malignancies worldwide. There is little information on the mechanisms involved in the pathogenesis of this disease. Diagnosis of HCC at early stages would be crucial for increasing the survival of patients. Circulating miRNAs have emerged as one of the most attractive tools for an early diagnosis of cancers. Various studies have shown that there is an aberrant expression of miRNAs such as miR-25, miR-375, miR-206, miR-223, miR- 92a, miR-222, miR-1, let-7f and miR-21 in HCC. Circulating and tissue miRNAs have also key roles in the pathogenesis of HCC by affecting several biologically important pathways such as p53, p21, PTEN, PI3K-AKT, c-Myc and STAT3. In this review, we summarize the current knowledge on the role of miRNAs in diagnosis, prognosis, and treatment of HCC.

1 June 2019 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
ETElahe Bahremandi Toloue
Elahe Bahremandi Toloue
Saeed KarbasiSaeed Karbasi
Saeed Karbasi
HSHossein Salehi
Hossein Salehi
MRMohammad Rafienia
Mohammad Rafienia